Results 171 to 180 of about 75,890 (310)

Treatment strategy for locally advanced pancreatic cancer

open access: yesSuizo, 2007
Kohei Nakachi   +5 more
openaire   +2 more sources

Relationship Between Radiographic and Pathological Portal Vein‐Superior Mesenteric Vein Involvement in Neoadjuvant Treatment for Pancreatic Cancer: A Comparative Study of Neoadjuvant Chemotherapy and Chemoradiotherapy

open access: yesWorld Journal of Surgery, EarlyView.
The relationship between the radiographic portal vein‐superior mesenteric vein (PV‐SMV) involvement and pathological PV‐SMV (pPV) invasion has been established in upfront surgery cases of pancreatic cancer (PC); however, evidence remains limited for patients receiving neoadjuvant therapy (NAT).
Naoko Sekiguchi   +13 more
wiley   +1 more source

Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 2025

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong   +28 more
wiley   +1 more source

The Possible Role of Immunotherapy in Locally Advanced Pancreatic Cancer Treatment. [PDF]

open access: yesActa Med Acad
Barakat R   +5 more
europepmc   +1 more source

Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen [PDF]

open access: yes, 2018
Bradley, Jeffrey   +10 more
core   +2 more sources

Treatment of locally advanced pancreatic cancer

open access: yes
This thesis aimed to evaluate the nationwide clinical practice and oncologic outcomes in the treatment of LAPC. 2. This chapter provides an overview of the clinical practice of treatment of LAPC patients. Median overall survival was 10 months. The majority of patients start with chemotherapy (77%).
openaire   +2 more sources

Are Social Media Platforms an Effective Forum for Engaging Early‐Onset Cancer Survivors? Insights From X (Formerly Twitter)

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This study presents a novel approach to understanding whether social media can be used to effectively communicate with cancer survivors. Posts generated by early‐onset cancer survivors were scarce, while clinician‐ and researcher‐produced content dominated.
Abby Dawson, Savio George Barreto
wiley   +1 more source

Home - About - Disclaimer - Privacy